5-Amino-1MQ

Certificate of Analysis & Complete Test Results

✓ Verified & Certified
Test Date
Jan 30, 2026
Batch Number
164160
Purity Level
99.83%

Certificate of Analysis

High-Performance Liquid Chromatography

Client: Peptides Canada
Sample Name: Cagrilintide + Semaglutide
Batch #: 164160
Report Date: 09/18/2025
Test: Purity
Receipt Date: 09/16/2025
Analysis Date: 09/18/2025
Matrix: Powder
Number of samples: 1
Purity: 99.83%

Research-grade specification: ≥95.0% — this batch exceeds specification.

Date File 164160_MS2_posneg_ Cagrilintide_Semaglutide _Lot164160_purity.d Sample Name Cagrilintide_Semaglutide _Lot164160_purity
Sample Type Sample Position P6-63
Instrument Name LCMS-7800 Series Username -
Acq Method Cagrlinide_Semaglutide_combo_purity_5mg.m Acquired 09/20/2025 10:09:15 AM
IRM Calibration Status Calibrated Time (UTC-07:00)
Comment Sample test for purity of Cagrlinide + Semaglutide batch 164160 DA Method SignalToNoiseCheckout.m
Sample Group Test Batch 5 Info. -
Stream Name LC1 Acquisition 09/20/2025 10:09:15 AM
Acquisition SW Version 6400 Series Triple Quadrupole B.09.00 (89037.0) Time (Local) (UTC-07:00)

Peak List

Time Area % Area
6.53 min 2521.6 49.83 %
7.18 min 2524.8 50.00%
8.42 min 36.5 0.72%

* determined as Cagrilintide (Amilyn Analogue) based on retention time

* determined as Semaglutide (GLP-1 Receptor Agonist) based on retention time

Note: Percent area between two compounds is not quantitative due to variable extinction coefficients.

Test Screen

UV Chromatogram:

Identity: Cagrilintide

(Other names: AM833, NN0174-0833)

CAS: 1415456-99-3

Identity: Semaglutide

(Other names: NNC 0113-0217,NN9535, Ozempic)

CAS: 910463-68-2

Data

Mass Spectrum

MSMS ID — head to tail database matching

Mass Spectrum Dual Peptide Envelope encompasses the 3-7 positive change states conferring Peptide Mass

Cagrilintide

Expected Mass: 4409.00

Observed Mass: 3931.64

Semaglutide

Expected Mass: 4113.64

Observed Mass: 4113.59

Reviewed and approved by:

Herman Lelie